Back
Abits Group Vs. Celldex Therapeutics Industry Stock Comparison
Sell
50
ABTS
Abits Group
Last Price:
0.45
Seasonality Move:
-20.37%
Sell
37
CLDX
Celldex Therapeutics
Last Price:
32.87
Seasonality Move:
1.08%
Sell
50
Abits Group (ABTS)
is a Sell
Is Abits Group a Buy, Sell or Hold?
- The current Abits Group [ABTS] share price is $0.50. The Score for ABTS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ABTS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics a Buy, Sell or Hold?
- The current Celldex Therapeutics [CLDX] share price is $36.02. The Score for CLDX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- CLDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABTS Stock Price Chart
What is Abits Group's stock price today?
-
The Abits Group share price today is $0.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABTS is experiencing selling pressure, which indicates risk of future bearish movement.
CLDX Stock Price Chart
What is Celldex Therapeutics's stock price today?
-
The Celldex Therapeutics share price today is $36.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDX is experiencing slight selling pressure.
ABTS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 49.58 | Sell |
Chaikin Money Flow: | -4355 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.47 - 0.53) | Sell |
Bollinger Bands (100): | (0.46 - 0.66) | Sell |
CLDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.42 | Buy |
Relative Strength Index (14 RSI): | 37.46 | Sell |
Chaikin Money Flow: | -2311480 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.03 - 43.15) | Sell |
Bollinger Bands (100): | (34.54 - 41.04) | Sell |
ABTS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.51 | Sell |
20-day SMA: | 0.49 | Buy |
50-day SMA: | 0.51 | Sell |
200-day SMA: | 0.74 | Sell |
8-day EMA: | 0.5 | Sell |
20-day EMA: | 0.5 | Sell |
50-day EMA: | 0.52 | Sell |
200-day EMA: | 0.69 | Sell |
CLDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.69 | Sell |
20-day SMA: | 41.52 | Sell |
50-day SMA: | 38.47 | Sell |
200-day SMA: | 38.87 | Sell |
8-day EMA: | 40.13 | Sell |
20-day EMA: | 40.37 | Sell |
50-day EMA: | 39.15 | Sell |
200-day EMA: | 37.62 | Sell |
Abits Group Earnings Growth & ABTS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Celldex Therapeutics Earnings Growth & CLDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
Abits Group Technical Analysis
Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Celldex Therapeutics Technical Analysis
Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |